{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T15:02:23Z","timestamp":1771599743345,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","award":["IR.SBMU.LASER.REC.1402.041"],"award-info":[{"award-number":["IR.SBMU.LASER.REC.1402.041"]}],"id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"DOI":"10.1007\/s10103-026-04825-4","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T13:57:34Z","timestamp":1771595854000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Photobiomodulation mitigates the inhibitory effects of pirfenidone on cancer-associated fibroblasts and their pro-tumorigenic properties: a cause for concern"],"prefix":"10.1007","volume":"41","author":[{"given":"Nima","family":"Rastegar-Pouyani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Nasirpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Javani Jouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Vazini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Moshaii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaber","family":"Zafari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"issue":"12","key":"4825_CR1","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen Y, McAndrews KM, Kalluri R (2021) Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat Reviews Clin Oncol 18(12):792\u2013804","journal-title":"Nat Reviews Clin Oncol"},{"issue":"7","key":"4825_CR2","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1080\/07357907.2023.2237576","volume":"41","author":"N Rastegar-Pouyani","year":"2023","unstructured":"Rastegar-Pouyani N, Montazeri V, Marandi N, Aliebrahimi S, Andalib M, Jafarzadeh E et al (2023) The impact of Cancer-Associated fibroblasts on drug resistance, stemness, and epithelial-mesenchymal transition in bladder cancer: A comparison between recurrent and non-recurrent patient-derived CAFs. Cancer Invest 41(7):656\u2013671","journal-title":"Cancer Invest"},{"issue":"3","key":"4825_CR3","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM et al (2020) A framework for advancing our Understanding of cancer-associated fibroblasts. Nat Rev Cancer 20(3):174\u2013186","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"4825_CR4","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41392-021-00641-0","volume":"6","author":"F Wu","year":"2021","unstructured":"Wu F, Yang J, Liu J, Wang Y, Mu J, Zeng Q et al (2021) Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer. Signal Transduct Target Therapy 6(1):218","journal-title":"Signal Transduct Target Therapy"},{"issue":"16","key":"4825_CR5","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.3390\/cancers14163906","volume":"14","author":"RA Glabman","year":"2022","unstructured":"Glabman RA, Choyke PL, Sato N (2022) Cancer-associated fibroblasts: tumorigenicity and targeting for cancer therapy. Cancers 14(16):3906","journal-title":"Cancers"},{"key":"4825_CR6","doi-asserted-by":"publisher","first-page":"121048","DOI":"10.1016\/j.lfs.2022.121048","volume":"309","author":"SA Antar","year":"2022","unstructured":"Antar SA, Saleh MA, Al-Karmalawy AA (2022) Investigating the possible mechanisms of Pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and\/or anti-SARS-CoV-2. Life Sci 309:121048","journal-title":"Life Sci"},{"key":"4825_CR7","doi-asserted-by":"publisher","first-page":"102624","DOI":"10.1016\/j.tice.2024.102624","volume":"91","author":"N Rastegar-Pouyani","year":"2024","unstructured":"Rastegar-Pouyani N, Abdolvahab MH, Farzin MA, Zare H, Kesharwani P, Sahebkar A (2024) Targeting cancer-associated fibroblasts with pirfenidone: A novel approach for cancer therapy. Tissue Cell 91:102624","journal-title":"Tissue Cell"},{"issue":"5","key":"4825_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1089\/pho.2017.4401","volume":"36","author":"MR Hamblin","year":"2018","unstructured":"Hamblin MR, Nelson ST, Strahan JR (2018) Photobiomodulation and cancer: what is the truth? Photomed Laser Surg 36(5):241\u2013245","journal-title":"Photomed Laser Surg"},{"issue":"6","key":"4825_CR9","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.3390\/jcm9061724","volume":"9","author":"C Dompe","year":"2020","unstructured":"Dompe C, Moncrieff L, Matys J, Grzech-Le\u015bniak K, Kocherova I, Bryja A et al (2020) Photobiomodulation\u2014underlying mechanism and clinical applications. J Clin Med 9(6):1724","journal-title":"J Clin Med"},{"issue":"3","key":"4825_CR10","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1109\/JSTQE.2016.2561201","volume":"22","author":"LF De Freitas","year":"2016","unstructured":"De Freitas LF, Hamblin MR (2016) Proposed mechanisms of photobiomodulation or low-level light therapy. IEEE J Sel Top Quantum Electron 22(3):348\u2013364","journal-title":"IEEE J Sel Top Quantum Electron"},{"key":"4825_CR11","first-page":"2781","volume":"24","author":"JA Zecha","year":"2016","unstructured":"Zecha JA, Raber-Durlacher JE, Nair RG, Epstein JB, Sonis ST, Elad S et al (2016) Low level laser therapy\/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations. Support Care Cancer 24:2781\u20132792","journal-title":"Support Care Cancer"},{"key":"4825_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.oraloncology.2019.04.004","volume":"93","author":"M de Pauli Paglioni","year":"2019","unstructured":"de Pauli Paglioni M, Ara\u00fajo ALD, Arboleda LPA, Palmier NR, Fons\u00eaca JM, Gomes-Silva W et al (2019) Tumor safety and side effects of photobiomodulation therapy used for prevention and management of cancer treatment toxicities. A systematic review. Oral Oncol 93:21\u201328","journal-title":"Oral Oncol"},{"issue":"3","key":"4825_CR13","first-page":"142","volume":"37","author":"SL Pinheiro","year":"2019","unstructured":"Pinheiro SL, Bonadiman AC, Borges Lemos ALA, Annicchino BM, Segatti B, Pucca DS et al (2019) Photobiomodulation therapy in cancer patients with mucositis: a clinical evaluation. Photobiomodul Photomed Laser Surg 37(3):142\u2013150","journal-title":"Photobiomodul Photomed Laser Surg"},{"key":"4825_CR14","volume-title":"Laser photobiomodulation (Pbm)\u2014A possible new frontier for the treatment of oral cancer: A review of in vitro and in vivo studies","year":"2021","unstructured":"Del Vecchio A, Tenore G, Luzi MC, Palaia G, Mohsen A, Pergolini D, Romeo U (eds) (2021) Laser photobiomodulation (Pbm)\u2014A possible new frontier for the treatment of oral cancer: A review of in vitro and in vivo studies. MDPI, Healthcare"},{"issue":"22","key":"4825_CR15","doi-asserted-by":"publisher","first-page":"8279","DOI":"10.1002\/cam4.3582","volume":"9","author":"RJ Bensadoun","year":"2020","unstructured":"Bensadoun RJ, Epstein JB, Nair RG, Barasch A, Raber-Durlacher JE, Migliorati C et al (2020) Safety and efficacy of photobiomodulation therapy in oncology: a systematic review. Cancer Med 9(22):8279\u20138300","journal-title":"Cancer Med"},{"key":"4825_CR16","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10103-019-02824-2","volume":"35","author":"JL da Silva","year":"2020","unstructured":"da Silva JL, Silva-de-Oliveira AFS, Andraus RAC, Maia LP (2020) Effects of low level laser therapy in cancer cells\u2014a systematic review of the literature. Lasers Med Sci 35:523\u2013529","journal-title":"Lasers Med Sci"},{"issue":"1","key":"4825_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/medicina56010015","volume":"56","author":"B Arneth","year":"2019","unstructured":"Arneth B (2019) Tumor microenvironment. Medicina 56(1):15","journal-title":"Medicina"},{"issue":"7","key":"4825_CR18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/intbio\/zyaa014","volume":"12","author":"H Aboulkheyr Es","year":"2020","unstructured":"Aboulkheyr Es H, Zhand S, Thiery JP, Warkiani ME (2020) Pirfenidone reduces immune-suppressive capacity of cancer-associated fibroblasts through targeting CCL17 and TNF-beta. Integr Biology 12(7):188\u2013197","journal-title":"Integr Biology"},{"issue":"6","key":"4825_CR19","doi-asserted-by":"publisher","first-page":"pdbprot095505","DOI":"10.1101\/pdb.prot095505","volume":"2018","author":"P Kumar","year":"2018","unstructured":"Kumar P, Nagarajan A, Uchil P (2018) Analysis of cell viability by the MTT assay. Cold Spring Harbor Protoc 2018(6):pdbprot095505","journal-title":"Cold Spring Harbor Protoc"},{"issue":"11","key":"4825_CR20","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.3390\/pharmaceutics15112550","volume":"15","author":"G Rastegar","year":"2023","unstructured":"Rastegar G, Salman MM, Sirsi SR (2023) Remote loading: the missing piece for achieving high drug payload and rapid release in polymeric microbubbles. Pharmaceutics 15(11):2550","journal-title":"Pharmaceutics"},{"issue":"1","key":"4825_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2174\/1573394713666170531081818","volume":"13","author":"E Hosseinzadeh","year":"2017","unstructured":"Hosseinzadeh E, Banaee N, Ali Nedaie H (2017) Cancer and treatment modalities. Curr Cancer Therapy Reviews 13(1):17\u201327","journal-title":"Curr Cancer Therapy Reviews"},{"key":"4825_CR22","doi-asserted-by":"publisher","first-page":"701122","DOI":"10.3389\/fonc.2021.701122","volume":"11","author":"Y Xia","year":"2021","unstructured":"Xia Y, Yu W, Cheng F, Rao T, Ruan Y, Yuan R et al (2021) Photobiomodulation with blue laser inhibits bladder cancer progression. Front Oncol 11:701122","journal-title":"Front Oncol"},{"issue":"3","key":"4825_CR23","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/php.13351","volume":"97","author":"S Shirazian","year":"2021","unstructured":"Shirazian S, Keykha E, Pourshahidi S, Ebrahimi H (2021) Effects of 660 Nm and 810 Nm low-power diode laser on proliferation and invasion of oral cancer cells in cell culture media. Photochem Photobiol 97(3):618\u2013626","journal-title":"Photochem Photobiol"},{"issue":"9","key":"4825_CR24","doi-asserted-by":"publisher","first-page":"5583","DOI":"10.1364\/BOE.427205","volume":"12","author":"H Goo","year":"2021","unstructured":"Goo H, Mo S, Park HJ, Lee MY, Ahn J-C (2021) Treatment with leds at a wavelength of 642 Nm enhances skin tumor proliferation in a mouse model. Biomedical Opt Express 12(9):5583\u20135596","journal-title":"Biomedical Opt Express"},{"issue":"2","key":"4825_CR25","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3390\/life13020320","volume":"13","author":"Y-Y Lin","year":"2023","unstructured":"Lin Y-Y, Lee S-Y, Cheng Y-J (2023) Low-level laser therapy induces melanoma tumor growth by promoting angiogenesis. Life 13(2):320","journal-title":"Life"},{"issue":"45","key":"4825_CR26","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1038\/onc.2008.271","volume":"27","author":"T Whiteside","year":"2008","unstructured":"Whiteside T (2008) The tumor microenvironment and its role in promoting tumor growth. Oncogene 27(45):5904\u20135912","journal-title":"Oncogene"},{"key":"4825_CR27","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2741\/3613","volume":"15","author":"F Xing","year":"2010","unstructured":"Xing F, Saidou J, Watabe K (2010) Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front Bioscience: J Virtual Libr 15:166","journal-title":"Front Bioscience: J Virtual Libr"},{"issue":"7","key":"4825_CR28","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.trecan.2022.03.001","volume":"8","author":"PE Saw","year":"2022","unstructured":"Saw PE, Chen J, Song E (2022) Targeting CAFs to overcome anticancer therapeutic resistance. Trends Cancer 8(7):527\u2013555","journal-title":"Trends Cancer"},{"issue":"4","key":"4825_CR29","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1165\/rcmb.2019-0328TR","volume":"62","author":"SM Ruwanpura","year":"2020","unstructured":"Ruwanpura SM, Thomas BJ, Bardin PG (2020) Pirfenidone: molecular mechanisms and potential clinical applications in lung disease. Am J Respir Cell Mol Biol 62(4):413\u2013422","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"12","key":"4825_CR30","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.3390\/ma14123427","volume":"14","author":"I Kocherova","year":"2021","unstructured":"Kocherova I, Bryja A, B\u0142ochowiak K, Kaczmarek M, Stefa\u0144ska K, Matys J et al (2021) Photobiomodulation with red and near-infrared light improves viability and modulates expression of mesenchymal and apoptotic-related markers in human gingival fibroblasts. Materials 14(12):3427","journal-title":"Materials"},{"issue":"5","key":"4825_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/or.2022.8315","volume":"47","author":"T Yoshimoto","year":"2022","unstructured":"Yoshimoto T, Shimada M, Tokunaga T, Nakao T, Nishi M, Takasu C et al (2022) Blue light irradiation inhibits the growth of colon cancer and activation of cancer\u2013associated fibroblasts. Oncol Rep 47(5):1\u20139","journal-title":"Oncol Rep"},{"key":"4825_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-016-2162-z","volume":"16","author":"M Mediavilla-Varela","year":"2016","unstructured":"Mediavilla-Varela M, Boateng K, Noyes D, Antonia SJ (2016) The anti-fibrotic agent Pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts. BMC Cancer 16:1\u20139","journal-title":"BMC Cancer"},{"issue":"1","key":"4825_CR33","doi-asserted-by":"publisher","first-page":"10900","DOI":"10.1038\/s41598-020-67904-8","volume":"10","author":"A Fujiwara","year":"2020","unstructured":"Fujiwara A, Funaki S, Fukui E, Kimura K, Kanou T, Ose N et al (2020) Effects of Pirfenidone targeting the tumor microenvironment and tumor-stroma interaction as a novel treatment for non-small cell lung cancer. Sci Rep 10(1):10900","journal-title":"Sci Rep"},{"key":"4825_CR34","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.34172\/jlms.2021.17","volume":"12","author":"J Zafari","year":"2021","unstructured":"Zafari J, Abbasinia H, Gharehyazi H, Javani Jouni F, Jamali S, Razzaghi M (2021) Evaluation of biological activity of different wavelengths of Low-Level laser therapy on the cancer prostate cell line compared with cisplatin. J Lasers Med Sci 12:e17","journal-title":"J Lasers Med Sci"},{"issue":"1","key":"4825_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12935-020-1100-y","volume":"20","author":"K Khorsandi","year":"2020","unstructured":"Khorsandi K, Kianmehr Z, hosseinmardi Z, Hosseinzadeh R (2020) Anti-cancer effect of Gallic acid in presence of low level laser irradiation: ROS production and induction of apoptosis and ferroptosis. Cancer Cell Int 20(1):18","journal-title":"Cancer Cell Int"},{"issue":"1","key":"4825_CR36","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12943-019-0994-2","volume":"18","author":"ME Fiori","year":"2019","unstructured":"Fiori ME, Di Franco S, Villanova L, Bianca P, Stassi G, De Maria R (2019) Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance. Mol Cancer 18(1):70","journal-title":"Mol Cancer"},{"issue":"46","key":"4825_CR37","doi-asserted-by":"publisher","first-page":"6679","DOI":"10.1038\/sj.onc.1204872","volume":"20","author":"AK Kiemer","year":"2001","unstructured":"Kiemer AK, Takeuchi K, Quinlan MP (2001) Identification of genes involved in epithelial-mesenchymal transition and tumor progression. Oncogene 20(46):6679\u20136688","journal-title":"Oncogene"},{"issue":"3","key":"4825_CR38","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial\u2013mesenchymal transition. Nat Rev Mol Cell Biol 15(3):178\u2013196","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1\u20133","key":"4825_CR39","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1159\/000101320","volume":"185","author":"MI Kokkinos","year":"2007","unstructured":"Kokkinos MI, Wafai R, Wong MK, Newgreen DF, Thompson EW, Waltham M (2007) Vimentin and Epithelial-Mesenchymal transition in human breast Cancer \u2013 Observations in vitro and in vivo. Cells Tissues Organs 185(1\u20133):191\u2013203","journal-title":"Cells Tissues Organs"},{"issue":"10","key":"4825_CR40","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3390\/cells8101118","volume":"8","author":"C-Y Loh","year":"2019","unstructured":"Loh C-Y, Chai JY, Tang TF, Wong WF, Sethi G, Shanmugam MK et al (2019) The E-Cadherin and N-Cadherin switch in Epithelial-to-Mesenchymal transition: Signaling, therapeutic Implications, and challenges. Cells 8(10):1118","journal-title":"Cells"},{"issue":"20","key":"4825_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers13205118","volume":"13","author":"HA Es","year":"2021","unstructured":"Es HA, Cox TR, Sarafraz-Yazdi E, Thiery JP, Warkiani ME (2021) Pirfenidone reduces epithelial-mesenchymal transition and spheroid formation in breast carcinoma through targeting Cancer-Associated fibroblasts (CAFs). Cancers (Basel) 13(20):1\u201315","journal-title":"Cancers (Basel)"},{"issue":"6","key":"4825_CR42","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1007\/s13577-022-00766-6","volume":"35","author":"J Liu","year":"2022","unstructured":"Liu J, Cao L, Li Y, Deng P, Pan P, Hu C, Yang H (2022) Pirfenidone promotes the levels of Exosomal miR-200 to down-regulate ZEB1 and represses the epithelial-mesenchymal transition of non-small cell lung cancer cells. Hum Cell 35(6):1813\u20131823","journal-title":"Hum Cell"},{"issue":"3","key":"4825_CR43","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s10103-020-03050-x","volume":"36","author":"Y Tian","year":"2021","unstructured":"Tian Y, Kim H, Kang HW (2021) In vitro anti-tumor effect of high-fluence low-power laser light on apoptosis of human colorectal cancer cells. Lasers Med Sci 36(3):513\u2013520","journal-title":"Lasers Med Sci"},{"issue":"1","key":"4825_CR44","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1038\/s41598-017-07144-5","volume":"7","author":"N Nair","year":"2017","unstructured":"Nair N, Calle AS, Zahra MH, Prieto-Vila M, Oo AKK, Hurley L et al (2017) A cancer stem cell model as the point of origin of cancer-associated fibroblasts in tumor microenvironment. Sci Rep 7(1):6838","journal-title":"Sci Rep"},{"issue":"9","key":"4825_CR45","first-page":"1889","volume":"9","author":"TX Huang","year":"2019","unstructured":"Huang TX, Guan XY, Fu L (2019) Therapeutic targeting of the crosstalk between cancer-associated fibroblasts and cancer stem cells. Am J Cancer Res 9(9):1889\u20131904","journal-title":"Am J Cancer Res"},{"issue":"27","key":"4825_CR46","doi-asserted-by":"publisher","first-page":"44917","DOI":"10.18632\/oncotarget.16570","volume":"8","author":"EL Wuebben","year":"2017","unstructured":"Wuebben EL, Rizzino A (2017) The dark side of SOX2: cancer - a comprehensive overview. Oncotarget 8(27):44917\u201344943","journal-title":"Oncotarget"},{"issue":"9","key":"4825_CR47","first-page":"483","volume":"32","author":"A Liu","year":"2013","unstructured":"Liu A, Yu X, Liu S (2013) Pluripotency transcription factors and cancer stem cells: small genes make a big difference. Chin J Cancer 32(9):483\u2013487","journal-title":"Chin J Cancer"},{"key":"4825_CR48","doi-asserted-by":"publisher","first-page":"146448","DOI":"10.1016\/j.gene.2022.146448","volume":"827","author":"P Vasefifar","year":"2022","unstructured":"Vasefifar P, Motafakkerazad R, Maleki LA, Najafi S, Ghrobaninezhad F, Najafzadeh B et al (2022) Nanog, as a key cancer stem cell marker in tumor progression. Gene 827:146448","journal-title":"Gene"},{"issue":"3","key":"4825_CR49","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10103-020-03131-x","volume":"36","author":"AMC de Ibarra","year":"2021","unstructured":"Ibarra AMC, Garcia MP, Ferreira M, de F\u00e1tima D, Pavani C, Mesquita-Ferrari RA et al (2021) Effects of photobiomodulation on cellular viability and cancer stem cell phenotype in oral squamous cell carcinoma. Lasers Med Sci 36(3):681\u2013690","journal-title":"Lasers Med Sci"},{"issue":"43","key":"4825_CR50","doi-asserted-by":"publisher","first-page":"7274","DOI":"10.1038\/sj.onc.1207947","volume":"23","author":"M Al-Hajj","year":"2004","unstructured":"Al-Hajj M, Clarke MF (2004) Self-renewal and solid tumor stem cells. Oncogene 23(43):7274\u20137282","journal-title":"Oncogene"},{"issue":"1","key":"4825_CR51","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12967-020-02260-9","volume":"18","author":"J Pei","year":"2020","unstructured":"Pei J, Wang Y, Li Y (2020) Identification of key genes controlling breast cancer stem cell characteristics via stemness indices analysis. J Translational Med 18(1):74","journal-title":"J Translational Med"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-026-04825-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-026-04825-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-026-04825-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T14:04:56Z","timestamp":1771596296000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-026-04825-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4825"],"URL":"https:\/\/doi.org\/10.1007\/s10103-026-04825-4","relation":{},"ISSN":["1435-604X"],"issn-type":[{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"31 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research and ethics committee of the Shahid Beheshti University of Medical Sciences, Laser Application in Medical Sciences Research Center has approved this study (IR.SBMU.LASER.REC.1402.041).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}